New - Data from the Imperial Clinical Program demonstrates ELUVIA more effective in diabetic patients January 22, 2019
Boston Scientific today announced diabetic
subanalysis results from the IMPERIAL trial in which patients treated with the ELUVIA™ Drug-Eluting Vascular Stent System demonstrated statistically significant lower rates of...
READ MORE
Media Contacts
Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com